Has Jeffrey Duncan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,557 in general payments to Jeffrey Duncan, MD across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Duncan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Duncan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Duncan, MD

Hospitalist · Daytona Beach, FLNPI 1639436066

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 33.4% of the total. Reporting peaked in 2024 at $674 and has fallen 78.8% since, to $143 in 2025. Among hospitalist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,557in general payments, 2019–2025

Across 100 payments — averaging $25.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$855
Pfizer$455
Johnson & Johnson$340
Edwards Lifesciences$234
Gilead$144
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$140
plus $388 from 7 others

What the payments were for

Food & beverage$2,557100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	44	$855
Pfizer	26	$455
Johnson & Johnson	13	$340
Edwards Lifesciences	3	$234
Gilead	2	$144
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	3	$140
AbbVie	1	$125
Novo Nordisk	1	$116
Boehringer Ingelheim	2	$47
Kestra Medical Technology Services, Inc.	2	$40
Ferring Pharmaceuticals Inc.	1	$22
Mallinckrodt Hospital Products Inc.	1	$22
Boston Scientific	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DALVANCE$125
PASCAL$123
Veklury$121
XARELTO$118
LifeVest$102
Edwards SAPIEN 3 Transcatheter Heart Valve$101

How this compares

$2,557 in reported general payments places this provider in the 95th percentile of 1,570 hospitalist providers in Florida.

See all hospitalist providers in Florida →

Medicare billing

Part B allowed, 2024

$96,260

Medicare patients

317

Services billed

1,083

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	21	$427
Pantoprazole Sodium	34	$329
CefuroximeCefuroxime Axetil	17	$217
Amlodipine Besylate	25	$173
Metoprolol Tartrate	19	$124
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$120
Doxycycline Hyclate	17	$108
Furosemide	23	$81
Famotidine	15	$70
Metoprolol Succinate	12	$61
Prednisone	25	$60
Atorvastatin Calcium	18	$57

Paid to pharmacies, not to this prescriber.

Other hospitalist in Daytona Beach

Murray EpsteinMiami$370K
Oliver AbelaFort Myers$77K
Joshua LenchusFort Lauderdale$73K
Tuncay TaskesenThe Villages$22K
Diego MunozApopka$17K
Francisco Perez LoretoMiami$17K
Tereese AllenTampa$11K
Timothy LongBay Pines$10K
Iahn GonsenhauserFort Myers$8K
Michael ShehataRiverview$7K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →